![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 3, 1856-1863, January 17, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Excitatory agonists can induce significant smooth
muscle contraction under constant free Ca2+ through a
mechanism called Ca2+ sensitization. Considerable evidence
suggests that free arachidonic acid plays an important role in
mediating agonist-induced Ca2+-sensitization; however, the
molecular mechanisms responsible for maintaining and regulating free
arachidonic acid level are not completely understood. In the current
study, we demonstrated that Ca2+-independent phospholipase
A2 (iPLA2) is expressed in vascular smooth
muscle tissues. Inhibition of the endogenous iPLA2 activity by bromoenol lactone (BEL) decreases basal free arachidonic acid levels
and reduces the final free arachidonic acid level after phenylephrine
stimulation, without significant effect on the net increase in free
arachidonic acid stimulated by phenylephrine. Importantly, BEL
treatment diminishes agonist-induced Ca2+ sensitization of
contraction from 49 ± 3.6 to 12 ± 1.0% (p < 0.01). In contrast, BEL does not affect agonist-induced
diacylglycerol production or contraction induced by
Ca2+, phorbol 12,13-dibutyrate (a protein kinase C
activator), or exogenous arachidonic acid. Further, we demonstrate that
adenovirus-mediated overexpression of exogenous
iPLA2 in mouse portal vein tissue significantly potentiates
serotonin-induced contraction. Our data provide the first evidence that
iPLA2 is required for maintaining basal free arachidonic
acid levels and thus is essential for agonist-induced Ca2+-sensitization of contraction in vascular smooth muscle.
Ca2+-independent Phospholipase
A2 Is Required for Agonist-induced Ca2+
Sensitization of Contraction in Vascular Smooth Muscle*
,
,
, and
¶
Department of Physiology, University of
Kentucky Medical Center, Lexington, Kentucky 40536 and the
§ Division of Experimental Diabetes and Aging, Department of
Geriatrics and Adult Development, Mount Sinai School of Medicine,
New York, New York 1002
*
This work was supported by National Institutes of Health
(NIH) Grant HL67284 (to M. C. G.) and by NINDS, NIH, Grant NS38126 (to G. M. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
K. M. Park, M. Trucillo, N. Serban, R. A. Cohen, and V. M. Bolotina Role of iPLA2 and store-operated channels in agonist-induced Ca2+ influx and constriction in cerebral, mesenteric, and carotid arteries Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1183 - H1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ihara, L. Moffat, J. Ostrander, M. P. Walsh, and J. A. MacDonald Characterization of protein kinase pathways responsible for Ca2+ sensitization in rat ileal longitudinal smooth muscle Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G699 - G710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bao, Y. Li, X. Lei, M. Wohltmann, W. Jin, A. Bohrer, C. F. Semenkovich, S. Ramanadham, I. Tabas, and J. Turk Attenuated Free Cholesterol Loading-induced Apoptosis but Preserved Phospholipid Composition of Peritoneal Macrophages from Mice That Do Not Express Group VIA Phospholipase A2 J. Biol. Chem., September 14, 2007; 282(37): 27100 - 27114. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xie, M. C. Gong, W. Su, J. Turk, and Z. Guo Group VIA Phospholipase A2 (iPLA2beta) Participates in Angiotensin II-induced Transcriptional Up-regulation of Regulator of G-protein Signaling-2 in Vascular Smooth Muscle Cells J. Biol. Chem., August 31, 2007; 282(35): 25278 - 25289. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Al-Alem, P. J Bridges, W. Su, M. C Gong, M. Iglarz, and C. Ko Endothelin-2 induces oviductal contraction via endothelin receptor subtype A in rats J. Endocrinol., June 1, 2007; 193(3): 383 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maeda, Y.-i. Ozaki, S. Sivakumaran, T. Akiyama, H. Urakubo, A. Usami, M. Sato, K. Kaibuchi, and S. Kuroda Ca-independent phospholipase A2-dependent sustained Rho-kinase activation exhibits all-or-none response. Genes Cells, September 1, 2006; 11(9): 1071 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bao, H. Song, M. Wohltmann, S. Ramanadham, W. Jin, A. Bohrer, and J. Turk Insulin Secretory Responses and Phospholipid Composition of Pancreatic Islets from Mice That Do Not Express Group VIA Phospholipase A2 and Effects of Metabolic Stress on Glucose Homeostasis J. Biol. Chem., July 28, 2006; 281(30): 20958 - 20973. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ko, M. C. Gieske, L. Al-Alem, Y. Hahn, W. Su, M. C. Gong, M. Iglarz, and Y. Koo Endothelin-2 in Ovarian Follicle Rupture Endocrinology, April 1, 2006; 147(4): 1770 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, Z. Guo, Z. Xie, W. Su, and M. C. Gong Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C892 - C899. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Gong, S. Arbogast, Z. Guo, J. Mathenia, W. Su, and M. B. Reid Calcium-independent phospholipase A2 modulates cytosolic oxidant activity and contractile function in murine skeletal muscle cells J Appl Physiol, February 1, 2006; 100(2): 399 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells Cardiovasc Res, February 1, 2006; 69(2): 491 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bao, A. Bohrer, S. Ramanadham, W. Jin, S. Zhang, and J. Turk Effects of Stable Suppression of Group VIA Phospholipase A2 Expression on Phospholipid Content and Composition, Insulin Secretion, and Proliferation of INS-1 Insulinoma Cells J. Biol. Chem., January 6, 2006; 281(1): 187 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo, W. Su, S. Allen, H. Pang, A. Daugherty, E. Smart, and M. C. Gong COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice Cardiovasc Res, September 1, 2005; 67(4): 723 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, Z. Guo, W. Su, Z. Xie, M. Eto, and M. C. Gong RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells Am J Physiol Cell Physiol, August 1, 2005; 289(2): C352 - C360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diebolt, L. Germain, F. A. Auger, and R. Andriantsitohaina Mechanism of potentiation by polyphenols of contraction in human vein-engineered media Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2918 - H2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Sun, J. Xu, M. D. Jensen, and A. Simonyi Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases J. Lipid Res., February 1, 2004; 45(2): 205 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. SOMLYO and A. V. SOMLYO Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase Physiol Rev, October 1, 2003; 83(4): 1325 - 1358. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |